-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cephalosporin antibacterial drugs are semi-synthetic antibacterial drugs synthesized by connecting the parent nucleus of cephalosporins with different side chains (7-ACA), and are the most widely used β-lactam antibacterial drugs
Concise comparison of the first and fifth generations of cephalosporin
Due to the variety of cephalosporins, the indications, antibacterial profiles, stability and adverse reactions of β-lactamase of each drug are not the same, which is easy to cause confusion and confusion, so we first make a simple comparison of the five generations of cephalosporins to facilitate memory
Table 1: Representative drugs of the fifth generation of cephalosporins
Clinically, there are also commonly used cefxitins, cefminol classified as the second generation; Laoxycephalosporin belongs to the third generation
Table 2: Antimicrobial profiles, enzyme stability and nephrotoxicity of five generations of cephalosporins
Second, the first generation of cephalosporins pharmacological characteristics
The first generation of cephalosporins was introduced in the early 1960s, mainly acting on aerobic gram-positive (G+) coccidioides, and only a small number of gram-negative (G-) bacillus have certain antibacterial activity
However, the resistance of the first generation of cephalosporin to the β-lactamase of G-bacteria is weak, it is easier to resist drugs, and the stability of the enzyme is not as good as that of the second and third generations
It is mainly used for respiratory tract, urinary tract, skin and soft tissue infections
Table 3: Pharmacological characteristics of first-generation cephalosporins
Third, the second generation of cephalosporin pharmacological characteristics
Compared with the first generation of cephalosporins, the antibacterial effect of the second generation of cephalosporins on G+ bacteria was slightly weakened, but the antibacterial effect and enzyme stability of G- bacteria were enhanced, and the nephrotoxicity was relatively small
It is commonly used to treat respiratory tract, biliary tract, intestinal urinary tract and soft tissue, bone and joint, obstetrics and gynecology infections
Table 4: Pharmacological characteristics of second-generation cephalosporins
Fourth, the pharmaceutical characteristics of the third generation of cephalosporins
The third generation of cephalosporins is a broad-spectrum antibacterial drug, its anti-G- bacteria activity is stronger (the antibacterial spectrum covers Pseudomonas aeruginosa), the effect on G+ bacteria is not as good as the first and second generations, and the β-lactamase is more stable, basically no nephrotoxicity
Clinically, it is mainly used for serious infections caused by sensitive bacteria such as urinary tract, respiratory tract, meningitis, sepsis and other infections
Table 5: Pharmacological characteristics of third-generation cephalosporins
Fifth, the fourth generation of cephalosporin pharmacological characteristics
Fourth-generation cephalosporin anti-G+ activity is similar to ceftriaxone, and anti-G-bacterial activity (including Pseudomonas aeruginosa) is similar to ceftazidime, which is more stable for β-lactamase but slightly less
Clinically, it is mainly used for various serious infections such as respiratory tract infections, urinary tract infections, biliary tract infections, sepsis, etc.
Table 6: Pharmacological characteristics of fourth-generation cephalosporins
Sixth, the fifth generation of cephalosporin pharmacological characteristics
Fifth-generation cephalosporins currently have only two types:
Currently, it is clinically approved for the treatment of community-acquired pneumonia and complex skin and skin tissue infections, including MRSA
Table 7: Pharmacological characteristics of fifth-generation cephalosporins
Seven and five generations of cephalosporin indications
Nephrotoxicity of the eighth and fifth generations of cephalosporin
Fifth generation (almost nothing) = fourth generation (little) < third generation (small) < second generation (smaller) < second generation (larger)
Cephalosporin antibiotics are mainly excreted by the kidneys, and patients with moderate or greater renal insufficiency should adjust the dose
The nephrotoxicity of the first generation of cephalosporins is large, and the combination with diuretics and aminoglycosides may aggravate the nephrotoxicity of the former, and attention should be paid to monitoring renal function
In moderate or above hepatic hypofunction, cefoperazone and ceftriaxone may need to be adjusted in dose
.
9.
Acute bacterial meningitis
Antibacterial drugs that easily cross the blood-brain barrier are selected, and if necessary, they are combined, and are generally administered intravenously at the maximum therapeutic dose
.
Ampicillin has excellent activity against Listeria mononuclearum, a cause of meningitis in immunocompromised patients
.
Ceftriaxone easily penetrates the blood-brain barrier, cefotaxime easily penetrates the inflamed meninges, and meropenem can achieve an effective concentration
in cerebrospinal fluid.
10.
Varieties that need to be tested
1.
The specification requires the variety of skin test
Ceftiam, cefmexime, cefminol sodium, ceftiazole sodium, cefotaxime sodium sulbactam sodium, cefotaphene sodium, etc
.
2.
Cross allergies between cephalosporins
Cefazolin, cefofuroxime, and cefotiam have the lowest similarities to other cephalosporin antibiotics, but cefotiam must be tested
in the skin.
3.
Cross allergy with penicillins
The incidence of cross-allergic reactions between first-generation cephalosporins and penicillins is about 4%;
The incidence of cross-allergic reactions between second-generation cephalosporins and penicillins is about 1%;
Third- and fourth-generation cephalosporins differ from penicillin-like side chains, and cross-allergic reactions are rare
.
11.
Disulfiram-like reaction
1.
Main mechanism
Inhibits the activity of acetaldehyde dehydrogenase, so that acetaldehyde accumulates in the blood, disulfiram-like reactions occur, facial flushing, headache, dizziness, abdominal pain, stomach pain, nausea, vomiting, rapid heartbeat, shortness of breath, chest tightness, decreased blood pressure, drowsiness, hallucinations, etc
.
2.
Represents the drug
The structure contains thiometrizozole groups of cephalosporin antibiotics, such as cefmendo, cefnixi, ceftiam, cefoperazone, cefomexime, cefpiramide, cefametazole, cefrazine, ceftitan, cefminol, laxercephalosporin, fluoxy cephalosporin and so on
.
Cephalosporin antibiotics without thiophotrezole groups in the molecule, such as ceftriaxone, cefazoline, cefotaxime, ceftazidime, ceftaxin, cefaclos, etc.
, can also cause disulfiram-like reactions
.
The mechanism of action needs to be further studied
.
11.
Be wary of cephalosporin encephalopathy
Mainly associated with antagonistic inhibitory transmitter γ-aminobutyric acid binding to receptors
.
Presents with hyperinstaticism, hallucinations, mania, limb tremors, and even induced epileptic or psychotic seizures
.
Patients with chronic renal insufficiency are susceptible to cephalosporin encephalopathy
.
Dicitracheal excretion of cefoperazone hepatic and renal channels, rarely causing antibiotic encephalopathy; 90% of cefotaxime and ceftazidime are excreted by the kidneys and should be avoided in patients with
chronic renal insufficiency.
Although ceftriaxone is excreted through the liver and kidney double channel, due to its good tissue permeability, it is easy to pass through the blood-brain barrier and also easily cause cephalosporin encephalopathy
.
Retrospective analysis found that cefepime caused the largest number of cases of encephalopathy, which may be related to almost all of its excretion through the kidneys
.
Resources:
[1] He Lixian et al.
National guidelines for antimicrobial therapy[M].
Beijing: People's Medical Publishing House, 2017: 342 pp.
Sanford Guidelines for Antimicrobial Therapy[M].
Beijing: Peking Union Medical College Press, 2017: 273 pp.
The difference between five generations of cephalosporins[J].
Health Management, 2017(12): 93-95.
Li Tongzeng.
Cephalosporin family generational view[J].
Physician Online, 2016, 6(19): 14-15.
[5] Sixteen cephalosporins are characterized and prescribed for administration,